November 26, 2013 (CHAPEL HILL, NC) Thought Leader Select, a consulting firm to the life sciences industries, recently earned new work in support of global key opinion leader (KOL) initiatives in diabetes for a top five global biopharmaceutical company.
The client company, one of the world’s top ten industry leaders in the development of medications across multiple therapeutic areas, tabbed North Carolina’s Thought Leader Select to assist them with upcoming and ongoing initiatives with global KOLs in diabetes, in support of its portfolio of insulin and other medications.
According to International Diabetes Federation estimates, nearly 400 million people worldwide suffer from some form of diabetes. That number is expected to escalate to nearly 600 million by 2035.
Thought Leader Select, headquartered in the Research Triangle region of North Carolina, provides research and consulting services to companies in the life sciences industry, including pharmaceutical, biotechnology, medical device, and diagnostics companies. These custom-tailored services support the necessary and critical industry outreach to and collaboration with leading medical experts, the health care professionals that advance treatment options and promote better public health at regional, national, and global levels.
For this global diabetes initiative, Thought Leader Select’s in-house research team will identify nearly 200 global KOLs in diabetes from a range of countries and regions, including the United States and Canada, western Europe, China, Latin America, Asia, and the Middle East. These experts have defined themselves in multiple areas of thought leadership, making their respective marks in advancing medical science in basic and clinical research, publishing in scientific journals, developing treatment guidelines, and serving on medical advisory boards and regulatory committees. In addition to these leading experts, Thought Leader Select will also identify the latest rising stars in the global diabetes treatment and research community, those who are already making a difference in the lives of patients and who will form the leading vanguard of thought leaders in diabetes in the generation to come.
After identification, Thought Leader Select will conduct in-depth, comprehensive profiling, in order to offer the client company a broad, deep understanding of the skills and experience, as well as the clinical and research interests of the new roster of key opinion leaders, many of whom will assist the company in the ongoing development of new medicines for treating diabetes.
The profiling work will serve as an objective, validated analytics foundation for understanding the professional social networks of the key opinion leaders through Thought Leader Select’s Professional Impact Network (PINs) mapping service. With PINs, Thought Leader Select shows known collaborations among KOLs in key areas of thought leadership that advance medical science, such as publishing in scientific journals, basic and clinical research, and advisory board work.
Thought Leader Select’s post-research advisory support will include engagement planning on strategic subjects such as advisory board and consultant selection, as well as KOL collaborations in publications and conference planning, patient advocacy work, and many other areas.
“Diabetes is an area where Thought Leader Select has a wealth of experience in helping companies optimize their key opinion leader relationships,” stated Neil Mellor, the company’s global business development consultant based in Toronto. “While there is much work being done here in North America, diabetes is a global challenge that deserves a global solution. Our client is bringing together the dedicated medical professionals who bring a global prospective, with proven experience in impacting the global medical community for the betterment of patients’ quality of life and public health outcomes.”
About Thought Leader Select
Thought Leader Select is a Chapel Hill, NC-based private consulting firm serving the biopharmaceutical, medical device, and diagnostics industries with strategies, in-house research, and a suite of engagement tools and support for collaborating with and reaching out to key opinion leaders and centers of excellence in medicine.
Thought Leader Select has supported dozens of companies as they develop effective treatments to promote better patient and public health across more than 18 therapeutic areas and 50 diseases and conditions. Thought Leader Select’s customized work strengthens medical marketing initiatives, medical affairs outreach, and payer marketing strategies to support market access, pricing, and reimbursement issues.
Media Contact:
Brian Castle, Director of Global Marketing and Client Relations
Phone: 919-360-9690
E-mail: bcastle@thoughtleaderselect.com
